Gemtuzumab ozogamicin: A component of induction therapy in AML?

Francis Giles

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Gemtuzumab ozogamicin: A component of induction therapy in AML?'. Together they form a unique fingerprint.